No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3Maria Wiese, Christof M. Kramm|Klinische Pädiatrie|2016Cited by 57